These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 17224277)
1. Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure. Buraczynska M; Ksiazek P; Kubit P; Zaluska W Cytokine; 2006 Nov; 36(3-4):167-72. PubMed ID: 17224277 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in Korean patients with adult-onset Still's disease. Youm JY; Woo JH; Kim TH; Bae SC; Yoo DH Scand J Rheumatol; 2007; 36(5):390-3. PubMed ID: 17963170 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis. Buraczynska M; Jozwiak L; Ksiazek P; Borowicz E; Mierzicki P Transl Res; 2007 Aug; 150(2):101-5. PubMed ID: 17656329 [TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824 [TBL] [Abstract][Full Text] [Related]
5. Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure. Shu KH; Cheng CH; Wu MJ; Chen CH; Lee WC Ren Fail; 2005; 27(1):53-7. PubMed ID: 15717635 [TBL] [Abstract][Full Text] [Related]
6. Role of non-HLA genetic variants in end-stage renal disease. Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039 [TBL] [Abstract][Full Text] [Related]
7. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients. Masutani K; Miyake K; Nakashima H; Hirano T; Kubo M; Hirakawa M; Tsuruya K; Fukuda K; Kanai H; Otsuka T; Hirakata H; Iida M Am J Kidney Dis; 2003 Feb; 41(2):371-9. PubMed ID: 12552499 [TBL] [Abstract][Full Text] [Related]
8. [Study on the polymorphism of interleukin-1 gene and the susceptibility to essential hypertension]. Li Y; Xu P; Zhang PA; Li XY; Huang CX Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):491-3. PubMed ID: 15476179 [TBL] [Abstract][Full Text] [Related]
9. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease. Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010 [TBL] [Abstract][Full Text] [Related]
11. Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer. Singh H; Sachan R; Goel H; Mittal B BJOG; 2008 Apr; 115(5):633-8. PubMed ID: 18333945 [TBL] [Abstract][Full Text] [Related]
12. IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population. Vishnoi M; Pandey SN; Choudhuri G; Mittal B Cancer Genet Cytogenet; 2008 Oct; 186(2):63-8. PubMed ID: 18940468 [TBL] [Abstract][Full Text] [Related]
13. Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India. Bid HK; Manchanda PK; Mittal RD Urology; 2006 May; 67(5):1099-104. PubMed ID: 16698387 [TBL] [Abstract][Full Text] [Related]
14. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes. Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860 [TBL] [Abstract][Full Text] [Related]
15. Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians. Achyut BR; Srivastava A; Bhattacharya S; Mittal B Clin Chim Acta; 2007 Feb; 377(1-2):163-9. PubMed ID: 17069782 [TBL] [Abstract][Full Text] [Related]
16. Effect of MDR1 gene polymorphism on progression of end-stage renal disease. Zhang WX; Chen B; Zhang W; Chen N; Yu ZC; Cai WM Acta Pharmacol Sin; 2007 Apr; 28(4):579-83. PubMed ID: 17376299 [TBL] [Abstract][Full Text] [Related]
17. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease. Buraczynska M; Ksiazek P; Zaluska W; Nowicka T; Ksiazek A Nephrol Dial Transplant; 2004 Sep; 19(9):2302-6. PubMed ID: 15299097 [TBL] [Abstract][Full Text] [Related]
18. Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients. Buraczynska M; Ksiazek P; Zukowski P; Benedyk-Lorens E; Orlowska-Kowalik G Clin Immunol; 2009 Aug; 132(2):285-90. PubMed ID: 19428307 [TBL] [Abstract][Full Text] [Related]
19. Genetic association of interleukin-1β (-511C/T) and its receptor antagonist (86-bpVNTR) gene polymorphism with susceptibility to bacteremia in kidney transplant recipients. Wan QQ; Ye QF; Ma Y; Zhou JD Transplant Proc; 2012 Dec; 44(10):3026-8. PubMed ID: 23195019 [TBL] [Abstract][Full Text] [Related]
20. Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study. Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B Hum Immunol; 2008 Mar; 69(3):179-86. PubMed ID: 18396210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]